Advertisement
Advertisement

BEAM

BEAM logo

Beam Therapeutics Inc

26.44
USD
-2.14
-7.49%
Dec 18, 15:59 UTC -5
Closed
...

Beam Therapeutics Inc Profile

About

Beam Therapeutics Inc. is a biotechnology company. It engages in developing precision genetic medicines through base editing. Beam Therapeutics Inc. is based in Cambridge, Massachusetts.

Info & Links

CEO

John Evans

Headquarters

238 Main Street
CAMBRIDGE, MA 02142, UNITED STATES

Auditor

Deloitte & Touche LLP

Share holders

33

Employees

436

Beam Therapeutics Inc Statistics

Valuation Measures

Market Capitalization2

2.19B

Enterprise Value

1.96B

Enterprise Value/EBITDA(ttm)

-10.52

Price to Earnings Ratio(ttm)

--

Price to Sales(ttm)

6.61

Price to Book(mrq)

2.92

Price to Cash(ytd)

--

Profitability

Gross Margin(ttm)

100.00%

Operating Margin(ttm)

-41.07%

Profit Margin(ttm)

-684.33%

Return on Equity(ttm)

-16.22%

Return on Invested Capital(ttm)

-19.13%

Return on Assets(ttm)

-10.94%

Income Statement

Revenue(ttm)

349.64M

Revenue Per Share(ttm)

4.22

Gross Profit(ttm)

349.64M

EBITDA(ttm)3

-186.31M

Net Income Available to Common(ttm)

-143.59M

Diluted EPS(ttm)

-1.76

Share Statistics

Beta (5Y Monthly)

1.90

52-Week Change

-10.55%

S&P 500 52-Week Change

23.87%

S&P 500 Member

Yes

Stock Optionable

Yes

Total Shares Outstanding1

82.81M

Dividend Yield

0.00%

Float4

79.33M

% Held by Insiders

4.20%

% Held by Institutions

99.68%

Balance Sheet

Total Cash(mrq)

925.76M

Total Cash Per Share(mrq)

11.18

Total Debt(mrq)

0.00

Total Debt/Equity(mrq)

0.00%

Current Ratio(mrq)

5.69%

Quick Ratio(mrq)

5.69%

Book Value Per Share(mrq)

9.58

Cash Flow

Operating Cash Flow Per Share(ytd)

-3.29

Free Cash Flow(ytd)

-276.86M

Table Key

mrq = Most Recent Quarter

ttm = Trailing Twelve Months

ytd = Year To Date

Footnotes

Data provided by Zacks Investment Research or calculated by FXEmpire. All numbers are rounded to the closest decimal.

  • 1 Total Shares outstanding is taken from the most recently filed quarterly or annual report.
  • 2 Market Cap is calculated using total shares outstanding and the most recent share price.
  • 3 EBITDA is calculated using methodology that may differ from that used by a company in its reporting.
  • 4 The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.
Advertisement